Company Profile

Year Established : 1992
Total Assets(USD) : More than 99,999,999
Total Number of Staff : more than 1000
Main Competitive Advantages : Brand Name,International Approvals/Standards,Experienced R&D Staff,Large Product Line,Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
  • Contact Person :
  • Fax:

Guangzhou Wondfo Biotech Co., Ltd., headquartered in Guangzhou Science City, has been focusing on the R&D, production, sales, and service of point-of-care testing (POCT) products and providing customers with professional rapid diagnosis and chronic disease management solutions since founded in 1992.

Since listed in Shenzhen Stock Exchange in 2015, Wondfo has undergone a great development and made remarkable progress in technology advancement and product innovation. Wondfo now has more than 2500 employees and a wide range of products for the rapid identification of cardiovascular diseases, inflammation, tumor, infectious diseases, drug abuse, pregnancy, and so on, widely sold to 140+ countries and regions.

Wondfo strives for excellence, sticks to the philosophy of "Earn everyone's trust by serving them the best", and makes every effort to meet the expectations of employees, customers, and partners.

Here, everything we do is to safeguard the health and improve the lives of people worldwide. With this in mind, we’ll continue to innovate and shape the future of POCT and healthcare.